Products were distributed in New York, Pennsylvania, Massachusetts, New Jersey, Maryland, Virginia, Washington, D.C., North ...

HHS sent an email to staff members that included a "whistle-blower questionnaire," and asked them to report cases of ...

Donanemab was approved by the FDA in July 2024 to treat adults with early symptomatic Alzheimer's disease with confirmed ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

One of the concerns people have when they hear FDA is using AI in the drug approval process is that many people don't have a ...

Stoboclo and Osenvelt, FDA-approved biosimilars of Prolia and Xgeva, are now available in the U.S. for variois cancers and ...

Millions at Risk: Popular Snack Poses Life-Threatening Threat to Peanut Allergy Sufferers Nationwide ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.

The ruling reverses the judge’s own decision from two years ago that allowed Washington state and 17 other states to continue ...

The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA ...

Head of Communications and Public Education at the Food and Drugs Authority (FDA), Rhoda Appiah, has called on Micro, Small & ...